Retatrutide is a new medication in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By stimulating these receptors, Retatrutide reduces hunger pangs, {promotesglucose regulation, and ultimately contributes to significant slimming. While st